Citations (85)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (21)
Michael R. Horsman. (2016) Realistic biological approaches for improving thermoradiotherapy. International Journal of Hyperthermia 32:1, pages 14-22.
Read now
Read now
Thomas R. Wittenborn & Michael R. Horsman. (2015) Targeting tumour hypoxia to improve outcome of stereotactic radiotherapy. Acta Oncologica 54:9, pages 1385-1392.
Read now
Read now
Michael R. Horsman. (2015) Therapeutic potential of using the vascular disrupting agent OXi4503 to enhance mild temperature thermoradiation. International Journal of Hyperthermia 31:5, pages 453-459.
Read now
Read now
Steffen L. Hokland, Thomas Nielsen, Morten Busk & Michael R. Horsman. (2010) Imaging tumour physiology and vasculature to predict and assess response to heat. International Journal of Hyperthermia 26:3, pages 264-272.
Read now
Read now
Xiaorong Sun, Ligang Xing, C. Clifton Ling & Gloria C. Li. (2010) The effect of mild temperature hyperthermia on tumour hypoxia and blood perfusion: relevance for radiotherapy, vascular targeting and imaging. International Journal of Hyperthermia 26:3, pages 224-231.
Read now
Read now
Michael R. Horsman. (2008) Angiogenesis and vascular targeting: Relevance for hyperthermia. International Journal of Hyperthermia 24:1, pages 57-65.
Read now
Read now
Michael R. Horsman. (2006) Tissue physiology and the response to heat. International Journal of Hyperthermia 22:3, pages 197-203.
Read now
Read now
M. R. Horsman & J. Overgaard. (1997) Hot Topic: Can mild hyperthermia improve tumour oxygenation?. International Journal of Hyperthermia 13:2, pages 141-147.
Read now
Read now
Pauline J. Wood, Michael R. Horsman, Azza A. Khalil, Fritz Steinberg, Christian Streffer, Jens Overgaard, Ian J. Stratford & Gerald E. Adams. (1996) A Comparison of the Physiological Effects of RSU1069 and RB6145 in the SCCVII Murine Tumour. Acta Oncologica 35:8, pages 989-994.
Read now
Read now
M. R. Horsman, L. E. Sampson, D. J. Chaplin & J. Overgaard. (1996) The in vivo interaction between flavone acetic acid and hyperthermia. International Journal of Hyperthermia 12:6, pages 779-789.
Read now
Read now
J. C. Lin, H. J. Park & C. W. Song. (1996) Combined treatment of IL-1α and TNF-α potentiates the antitumour effect of hyperthermia. International Journal of Hyperthermia 12:3, pages 335-344.
Read now
Read now
Olav Dahl & Jens Overgaard. (1995) A Century With Hyperthermic Oncology In Scandinavia. Acta Oncologica 34:8, pages 1075-1083.
Read now
Read now
S. L. Brown, X. L. Li, H. H. Pai, A. E. Worthington, R. P. Hill & J. W. Hunt. (1992) Observations of thermal gradients in perfused tissues during water bath heating. International Journal of Hyperthermia 8:2, pages 275-287.
Read now
Read now
R. V. Fisker, M. R. Horsman & J. Overgaard. (1991) Hydralazine-induced Changes in Tissue Perfusion and Radiation Response in A C3H Mammary Carcinoma and Mouse Normal Tissues. Acta Oncologica 30:5, pages 641-647.
Read now
Read now
D. J. Honess, D. E. Hu & N. M. Bleehen. (1991) A study of the mechanism of hydralazine enhancement of thermal damage in the KHT tumour. International Journal of Hyperthermia 7:4, pages 667-679.
Read now
Read now
M.R. Horsman, D.J. Chaplin & J. Overgaard. (1991) The Effect of Combining Flavone Acetic Acid and Hyperthermia on the Growth of a C3H Mammary Carcinoma in Vivo. International Journal of Radiation Biology 60:1-2, pages 385-388.
Read now
Read now
D.J. Chaplin. (1991) The Effect of Therapy on Tumour Vascular Function. International Journal of Radiation Biology 60:1-2, pages 311-325.
Read now
Read now
S.B. Field, I.A. Burney, S. Needham, R.J. Maxwell, J. Coggle & J.R. Griffiths. (1991) Are Transplanted Tumours Suitable as Models for Studies on Vasculature. International Journal of Radiation Biology 60:1-2, pages 255-260.
Read now
Read now
D.J. Honess & N.M. Bleehen. (1991) Effects of Two Tumour Blood Flow Modifiers, Hydralazine and Flavone Acetic Acid, on KHT Tumours and Normal Tissues in Mice. International Journal of Radiation Biology 60:1-2, pages 249-253.
Read now
Read now
D.G. Hirst, V.K. Hirst, K.M. Shaffi, V.E. Prise & B. Joiner. (1991) The Influence of Vasoactive Agents on the Perfusion of Tumours Growing in Three Sites in the Mouse. International Journal of Radiation Biology 60:1-2, pages 211-218.
Read now
Read now
M. W. Dewhirst, D. M. Prescott, S. Clegg, T. V. Samulski, R. L. Page, D. E. Thrall, K. Leopold, G. Rosner, J. C. Acker & J. R. Oleson. (1990) The use of hydralazine to manipulate tumour temperatures during hyperthermia. International Journal of Hyperthermia 6:6, pages 971-983.
Read now
Read now
Articles from other publishers (64)
M.R. Horsman, B.S. Sørensen, M. Busk & D.W. Siemann. (2021) Therapeutic Modification of Hypoxia. Clinical Oncology 33:11, pages e492-e509.
Crossref
Crossref
Mrigendra B. Karmacharya, Laith R. Sultan, Stephen J. Hunt & Chandra M. Sehgal. (2021) Hydralazine augmented ultrasound hyperthermia for the treatment of hepatocellular carcinoma. Scientific Reports 11:1.
Crossref
Crossref
Michael R. Horsman & Peter Vaupel. (2016) Pathophysiological Basis for the Formation of the Tumor Microenvironment. Frontiers in Oncology 6.
Crossref
Crossref
Kenya Murase, Yoshinori Kusakabe & Shohei Miyazaki. (2016) Quantitative Assessment of the Effect of Nitric Oxide Synthase Inhibition on Tumor Vascular Activity Using Dynamic Contrast-Enhanced Computed Tomography. Open Journal of Medical Imaging 06:02, pages 42-52.
Crossref
Crossref
Dietmar W. Siemann & Michael R. Horsman. (2015) Modulation of the tumor vasculature and oxygenation to improve therapy. Pharmacology & Therapeutics 153, pages 107-124.
Crossref
Crossref
David Cragg, Gordon Kingston & David NewmanKevin Pinney, George Pettit, Mary Trawick, Christopher Jelinek & David Chaplin. 2011. Anticancer Agents from Natural Products, Second Edition. Anticancer Agents from Natural Products, Second Edition
27
64
.
Morten Busk, Anja Bille Bohn, Marianne Skals, Tobias Wang & Michael R. Horsman. (2011) Combretastatin-induced hypertension and the consequences for its combination with other therapies. Vascular Pharmacology 54:1-2, pages 13-17.
Crossref
Crossref
Henry C. Mandeville & Peter J. Hoskin. 2010. Vascular Disruptive Agents for the Treatment of Cancer. Vascular Disruptive Agents for the Treatment of Cancer
231
250
.
Pierre Sonveaux. (2008) Provascular strategy: Targeting functional adaptations of mature blood vessels in tumors to selectively influence the tumor vascular reactivity and improve cancer treatment. Radiotherapy and Oncology 86:3, pages 300-313.
Crossref
Crossref
M.R. Horsman & J. Overgaard. (2007) Hyperthermia: a Potent Enhancer of Radiotherapy. Clinical Oncology 19:6, pages 418-426.
Crossref
Crossref
Michael R. Horsman & Dietmar W. Siemann. (2006) Pathophysiologic Effects of Vascular-Targeting Agents and the Implications for Combination with Conventional Therapies. Cancer Research 66:24, pages 11520-11539.
Crossref
Crossref
Gian Franco Baronzio, Vincenzo Cerreta, Attilio Baronzio, Isabel Freitas, Marco Mapelli & Alberto Gramaglia. 2006. Hyperthermia in Cancer Treatment: A Primer. Hyperthermia in Cancer Treatment: A Primer
128
155
.
David Chaplin, Christopher Jelinek, George Pettit, Klaus Edvardsen & Kevin Pinney. 2005. Anticancer Agents from Natural Products. Anticancer Agents from Natural Products.
Lise Bentzen, Peter Vestergaard-Poulsen, Thomas Nielsen, Jens Overgaard, Atle Bjørnerud, Karen Briley-Sæbø, Michael R. Horsman & Leif Østergaard. (2005) Intravascular contrast agent–enhanced MRI measuring contrast clearance and tumor blood volume and the effects of vascular modifiers in an experimental tumor. International Journal of Radiation Oncology*Biology*Physics 61:4, pages 1208-1215.
Crossref
Crossref
Morikazu AMANO, Hajime MONZEN, Minoru SUZUKI, Kaoru TERAI, Satoshi ANDOH, Akio TSUMURAYA & Takeo HASEGAWA. (2005) Increase in Tumor Oxygenation and Potentiation of Radiation Effects Using Pentoxifylline, Vinpocetine and Ticlopidine Hydrochloride. Journal of Radiation Research 46:4, pages 373-378.
Crossref
Crossref
Ryoji Tokiya, Keiji Umetani, Shigeki Imai, Takenori Yamashita, Junichi Hiratsuka & Yoshinari Imajo. (2004) Observation of microvasculatures in athymic nude rat transplanted tumor using synchrotron radiation microangiography system1. Academic Radiology 11:9, pages 1039-1046.
Crossref
Crossref
Dietmar W. Siemann, David J. Chaplin & Michael R. Horsman. (2004) Vascular-targeting therapies for treatment of malignant disease. Cancer 100:12, pages 2491-2499.
Crossref
Crossref
Thomas G Purdie & Ting-Yim Lee. (2003) Carbon dioxide reactivity of computed tomography functional parameters in rabbit VX2 soft tissue tumour. Physics in Medicine and Biology 48:7, pages 849-860.
Crossref
Crossref
Michael R Horsman & Rumi Murata. (2002) Combination of vascular targeting agents with thermal or radiation therapy. International Journal of Radiation Oncology*Biology*Physics 54:5, pages 1518-1523.
Crossref
Crossref
Michael Kragh, Bjørn Quistorff, Michael R. Horsman & Paul E.G. Kristjansen. (2002) Acute Effects of Vascular Modifying Agents in Solid Tumors Assessed by Noninvasive Laser Doppler Flowmetry and Near Infrared Spectroscopy. Neoplasia 4:3, pages 263-267.
Crossref
Crossref
Rumi Murata, Jens Overgaard & Michael R Horsman. (2001) Combretastatin A-4 disodium phosphate: a vascular targeting agent that improves that improves the anti-tumor effects of hyperthermia, radiation, and mild thermoradiotheraphy. International Journal of Radiation Oncology*Biology*Physics 51:4, pages 1018-1024.
Crossref
Crossref
Bruce M Fenton. (2001) Influence of hydralazine administration on oxygenation in spontaneous and transplanted tumor models. International Journal of Radiation Oncology*Biology*Physics 49:3, pages 799-808.
Crossref
Crossref
C. W. Song. 2000. Blood Perfusion and Microenvironment of Human Tumors. Blood Perfusion and Microenvironment of Human Tumors
193
207
.
R. J. Maxwell. 2000. Blood Perfusion and Microenvironment of Human Tumors. Blood Perfusion and Microenvironment of Human Tumors
145
159
.
M. R. Horsman, R. Murata, T. Breidahl, F. U. Nielsen, R. J. Maxwell, H. Stødkiled-Jørgensen & J. Overgaard.. 2000. Angiogenesis. Angiogenesis
311
323
.
F. U. Nielsen, S. Topp, M. R. Horsman, J. Overgaard, H. Stødkilde-Jørgensen & R. J. Maxwell. (1999) Localizedin vivo1H NMR spectroscopy of murine tumours: effect of blood flow reduction. NMR in Biomedicine 12:4, pages 175-183.
Crossref
Crossref
David J. Chaplin, Sally A. Hill, Katrina M. Bell & Gillian M. Tozer. (1998) Modification of tumor blood flow: Current status and future directions. Seminars in Radiation Oncology 8:3, pages 151-163.
Crossref
Crossref
G.M. Tozer & S.A. Everett. (1997) Nitric oxide in tumour biology and cancer therapy. Part 2: Therapeutic implications. Clinical Oncology 9:6, pages 357-364.
Crossref
Crossref
Bård Kronen Krossnes, Olav Mella & Ingvald Tyssebotn. (1996) Effect of sodium nitroprusside-induced hypotension on the blood flow in subcutaneous and intramuscular BT4An tumors and normal tissues in rats. International Journal of Radiation Oncology*Biology*Physics 36:2, pages 393-401.
Crossref
Crossref
Bård Kronen Krossnes, Olav Mella & Olav Dahl. (1996) Use of the vasodilator sodium nitroprusside during local hyperthermia: Effects on tumor temperature and tumor response in a rat tumor model. International Journal of Radiation Oncology*Biology*Physics 36:2, pages 403-415.
Crossref
Crossref
Franklyn A. Howe, Simon P. Robinson & John R. Griffiths. (1996) Modification of Tumour Perfusion and Oxygenation Monitored by Gradient Recalled Echo MRI and31P MRS. NMR in Biomedicine 9:5, pages 208-216.
Crossref
Crossref
Sergey V. Kozin, Takeo Hasegawa, Sang Kil Ha-Kawa, Kiyoshi Akagi & Yoshimasa Tanaka. (1994) Hydralazine at thermoradiotherapy: Tumor size and blood flow effects. International Journal of Radiation Oncology*Biology*Physics 29:3, pages 505-510.
Crossref
Crossref
Charles A. Belfi, Chitta R. Paul, Siqing Shan & Frank Q.H. Ngo. (1994) Comparison of the effects of hydralazine on tumor and normal tissue blood perfusion by MRI. International Journal of Radiation Oncology*Biology*Physics 29:3, pages 473-479.
Crossref
Crossref
Cai Grau, Marianne Nordsmark, Azza A. Khalil, Michael R. Horsman & Jens Overgaard. (1994) Effect of carbon monoxide breathing on hypoxia and radiation response in the SCCVII tumor in vivo. International Journal of Radiation Oncology*Biology*Physics 29:3, pages 449-454.
Crossref
Crossref
Chang W. Song, Carol M. Makepeace, Robert J. Griffin, Takeo Hasegawa, James L. Osborn, Ihl-Bohng Choi & Byung S. Nah. (1994) Increase in tumor blood flow by pentoxifylline. International Journal of Radiation Oncology*Biology*Physics 29:3, pages 433-437.
Crossref
Crossref
D.J. Chaplin & M.R. Horsman. (1994) The influence of tumour temperature on ischemia-induced cell death: potential implications for the evaluation of vascular mediated therapies. Radiotherapy and Oncology 30:1, pages 59-65.
Crossref
Crossref
Michael R. Horsman, Azza A. Khalil, Marianne Nordsmark, Cai Grau & Jens Overgaard. 1994. Oxygen Transport to Tissue XV. Oxygen Transport to Tissue XV
493
500
.
D. J. Chaplin & M. R. Horsman. 1994. Oxygen Transport to Tissue XV. Oxygen Transport to Tissue XV
437
443
.
Jane C. M. Bremner. (1993) Assessing the bioreductive effectiveness of the nitroimidazole RSU1069 and its prodrug RB6145: with particular reference toin vivo methods of evaluation. Cancer and Metastasis Reviews 12:2, pages 177-193.
Crossref
Crossref
Davina J. Honess & Norman M. Bleehen. (1993) Effects of the radiosensitising agent nicotinamide on relative tissue perfusion and kidney function in C3H mice. Radiotherapy and Oncology 27:2, pages 140-148.
Crossref
Crossref
M. R. Horsman. 1993. Current Topics in Clinical Radiobiology of Tumors. Current Topics in Clinical Radiobiology of Tumors
99
112
.
Mark W. Dewhirst, David Madwed, Robert E. Meyer, Edgardo T. Ong, Bruce Klitzman, Gary L. Rosner & Richard Dodge. (2007) Reduction in tumor blood flow in skin flap tumor after hydralazine is not due to a vascular steal phenomenon. Radiation Oncology Investigations 1:5, pages 270-278.
Crossref
Crossref
Michael R. Horsman & Jens Overgaard. (1992) BW12C-induced changes in haemoglobin-oxygen affinity in mice and its influence on the radiation response of a C3H mouse mammary carcinoma. Radiotherapy and Oncology 25:1, pages 43-48.
Crossref
Crossref
G. M. Tozer & J. R. Griffiths. (2011)
The contribution made by cell death and oxygenation to
31
P MRS observations of tumour energy metabolism
. NMR in Biomedicine 5:5, pages 279-289.
Crossref
Crossref
Z. M. Bhujwalla, S. J. Blackband, J. P. Wehrle & J. D. Glickson. (2005)
Spatial heterogeneity of the metabolic response of RIF‐1 tumors to a vasoactive agent evaluated
in vivo
by one‐dimensional
31
P chemical‐shift imaging
. Magnetic Resonance in Medicine 26:2, pages 308-312.
Crossref
Crossref
Michael R. Horsman, Jacob C. Lindegaard & Jens Overgaard. 1992. Congress Proceedings. Congress Proceedings
1033
1040
.
Michael R. Horsman & J. Overgaard. (1992) Overcoming tumour radiation resistance resulting from acute hypoxia. European Journal of Cancer 28:12, pages 2084-2085.
Crossref
Crossref
Helen B. Stone, Andrew I. Minchinton, Marilyn Lemmon, Douglas Menke & J.Martin Brown. (1992) Pharmacological modification of tumor blood flow: Lack of correlation between alteration of mean arterial blood pressure and changes in tumor perfusion. International Journal of Radiation Oncology*Biology*Physics 22:1, pages 79-86.
Crossref
Crossref
Carrie E. Peters & David J. Chaplin. (1992) Blood flow modification in the sccvii tumor: Effects of 5-Hydroxytryptamine, hydralazine, and propanolol. International Journal of Radiation Oncology*Biology*Physics 22:3, pages 463-465.
Crossref
Crossref
David J. Chaplin & Michael R. Horsman. (1992) Tumor blood flow changes induced by chemical modifiers of radiation response. International Journal of Radiation Oncology*Biology*Physics 22:3, pages 459-462.
Crossref
Crossref
Michael R. Horsman, Kent L. Christensen & Jens Overgaard. (1992) Relationship between the hydralazine-induced changes in murine tumor blood supply and mouse blood pressure. International Journal of Radiation Oncology*Biology*Physics 22:3, pages 455-458.
Crossref
Crossref
Michael R. Horsman, Paul E.G. Kristjansen, Masao Mizuno, Kent L. Christensen, David J. Chaplin, Bj?rn Quistorff & Jens Overgaard. (1992) Biochemical and physiological changes induced by nicotinamide in a C3H mouse mammary carcinoma and CDF1 mice. International Journal of Radiation Oncology*Biology*Physics 22:3, pages 451-454.
Crossref
Crossref
Cai Grau, Michael R. Horsman & Jens Overgaard. (1992) Influence of carboxyhemoglobin level on tumor growth, blood flow, and radiation response in an experimental model. International Journal of Radiation Oncology*Biology*Physics 22:3, pages 421-424.
Crossref
Crossref
Cai Grau, Michael R. Horsman & Jens Overgaard. (1992) Improving the radiation response in a c3h mouse mammary carcinoma by normobaric oxygen or carbogen breathing. International Journal of Radiation Oncology*Biology*Physics 22:3, pages 415-419.
Crossref
Crossref
D.J. Honess & N.M. Bleehen. (1992) Comparative effects of hydralazine on perfusion of kht tumor, kidney and liver and on renal function in mice. International Journal of Radiation Oncology*Biology*Physics 22:5, pages 953-961.
Crossref
Crossref
M. R. Horsman & J. Overgaard. 1992. Interstitial Hyperthermia. Interstitial Hyperthermia
11
33
.
Takeo Hasegawa & Chang W. Song. (1991) Effect of hydralazine on the blood flow in tumors and normal tissues in rats. International Journal of Radiation Oncology*Biology*Physics 20:5, pages 1001-1007.
Crossref
Crossref
David J. Chaplin, Carrie E. Peters, Michael R. Horsman & Martin J. Trotter. (1991) Drug induced perturbations in tumor blood flow: therapeutic potential and possible limitations. Radiotherapy and Oncology 20, pages 93-101.
Crossref
Crossref
G.E. Adams, I.J. Stratford, J.C.M. Bremner, S. Cole, H.S. Edwards & E.M. Fielden. (1991) Nitroheterocyclic compounds as radiation sensitizers and bioreductive drugs. Radiotherapy and Oncology 20, pages 85-91.
Crossref
Crossref
Michael R. Horsman, David J. Chaplin & Jens Overgaard. (1991) The use of blood flow modifiers to improve the treatment response of solid tumors. Radiotherapy and Oncology 20, pages 47-52.
Crossref
Crossref
Zaver M. Bhujwalla, Gillian M. Tozer, Stanley B. Field, Ross J. Maxwell & John R. Grifflths. (1990) The energy metabolism of RIF-1 tumours following hydralazine. Radiotherapy and Oncology 19:3, pages 281-291.
Crossref
Crossref
Z. M. Bhujwalla, G. M. Tozer, S. B. Field, E. Proctor, A. Busza & S. R. Williams. (1990) The combined measurement of blood flow and metabolism in RIF-1 tumoursin vivo. A study using H2 flow and31P NMR spectroscopy. NMR in Biomedicine 3:4, pages 178-183.
Crossref
Crossref
P. Vaupel. 1990. Biological Basis of Oncologic Thermotherapy. Biological Basis of Oncologic Thermotherapy
73
134
.
Michael R. Horsman, Kent L. Christensen, David J. Chaplin & Jens Overgaard. 1990. Selective Activation of Drugs by Redox Processes. Selective Activation of Drugs by Redox Processes
193
202
.